Other OTC - Delayed Quote USD

Cordlife Group Limited (CLIFF)

0.2984 0.0000 (0.00%)
As of November 30 at 9:30 AM EST. Market Open.
Loading Chart for CLIFF
DELL
  • Previous Close 0.2984
  • Open 0.2984
  • Bid --
  • Ask --
  • Day's Range 0.2984 - 0.2984
  • 52 Week Range 0.2000 - 0.3763
  • Volume 1,850
  • Avg. Volume 0
  • Market Cap (intraday) 76.482M
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) 14.92
  • EPS (TTM) 0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 6, 2022
  • 1y Target Est --

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. The company operates through two segments, Banking and Diagnostics. It offers cord blood, cord lining, and cord tissue banking services, including processing and storage of stem cells; and various diagnostics services, such as newborn genetic screening, pediatric vision and ear screening, pediatric allergen test, genetic talent test, preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing, and newborn metabolic screening. The company also provides Moms Up, a mobile app for pregnancy and parenting resources for moms and moms-to-be. In addition, it provides medical laboratory, marketing, and property investment services. Cordlife Group Limited was incorporated in 2001 and is headquartered in Singapore.

www.cordlife.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLIFF

Performance Overview: CLIFF

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CLIFF
0.00%
STI Index
1.23%

1-Year Return

CLIFF
49.20%
STI Index
0.50%

3-Year Return

CLIFF
18.23%
STI Index
2.69%

5-Year Return

CLIFF
0.25%
STI Index
2.09%

Compare To: CLIFF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLIFF

Valuation Measures

Annual
As of 2/27/2024
  • Market Cap

    23.53M

  • Enterprise Value

    -25.26M

  • Trailing P/E

    19.65

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.79

  • Price/Book (mrq)

    0.76

  • Enterprise Value/Revenue

    -0.44

  • Enterprise Value/EBITDA

    -2.51

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.64%

  • Return on Assets (ttm)

    -0.06%

  • Return on Equity (ttm)

    2.78%

  • Revenue (ttm)

    55.92M

  • Net Income Avi to Common (ttm)

    3.71M

  • Diluted EPS (ttm)

    0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    65.01M

  • Total Debt/Equity (mrq)

    2.58%

  • Levered Free Cash Flow (ttm)

    4.7M

Company Insights: CLIFF